The global muscle relaxant drugs market is growing, due to increasing aging population, increasing incidences of skin diseases and harmful effects of ultra violet radiation. In addition, the increasing usage of neuromuscular blocking agents in surgeries, and increase in disposable income are also driving the growth of the global muscle relaxant drugs market.
The information and data in the publication “Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by type and drugs. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.
The increasing aging population is propelling the growth of the global muscle relaxant drugs market, since the elder population is more prone to illness due to low immunity levels, and high recovery time consumption. Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. The muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.
However, the high capital expenditure, stringent regulatory requirements, and risks associated with muscle relaxants are inhibiting the growth of the global market. The tradition of online shopping for muscle relaxant drugs and their increasing usage in cosmetic industry are the major trends observed in the global muscle relaxant drugs market.
Geographically, North America dominated the global market of muscle relaxant drugs in 2014; whereas the Asian market is expected to witness the fastest growth during the forecast period.
The key companies operating in the global muscle relaxant drugs market include F. Hoffmann-La Roche Ltd., Johnson & Johnson, GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Pfizer Inc., Galderma S.A., and Merck & Co. Inc.
In terms of type, facial aesthetic relaxants held the largest share of the muscle relaxant drugs market during the historical period (2011–2014). This category is also expected to grow at the fastest pace during the forecast period due to the high efficiency and safety of such drugs.
Skeletal muscle relaxants are of two types: antispastic and antispasmodic agents. For conditions such as cerebral palsy and multiple sclerosis, antispastic agents are used, while antispasmodic agents are used for managing musculoskeletal conditions including lower back pain, tension headaches, and neck pain. Due to the availability of effective therapies and growing aging population, antispasmodic agents are used more frequently to manage musculoskeletal conditions.
GLOBAL MUSCLE RELAXANT DRUGS MARKET SEGMENTATION
- Facial Aesthetic Relaxants
- Skeletal Muscle Relaxants
- Neuromuscular Blocking Agents
- Facial Aesthetic Relaxant Drugs
- Skeletal Muscle Relaxant Drugs
- Neuromuscular Blocking Agents
o Non-Depolarizing Agents
o Polarizing Agents
Breakdown by Geography
- North America
o The U.S.
o Rest of North America
o The U.K.
o Rest of Europe
o Rest of Asia
- Rest of the World (RoW)